Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

Natera

CareDx

Veracyte

Schrodinger 

Guardant Health Inc

Adaptive Biotechnologies

Beam Therapeutics

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Biotech ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Xtrackers Harvest CSI 300 China A-Shares ETF

Amplify Alternative Harvest ETF

Find out how one of these exchange-traded funds took investors higher than any other.

These 3 ETFs Have Crushed It in 2019

Breakwave Dry Bulk Shipping ETF

VanEck Vectors ChinaAMC SME-ChiNext ETF

AdvisorShares Dorsey Wright Short ETF

ProShares VIX Short-Term Futures ETF

We have highlighted both the best and worst performing ETFs of Q1 from different zones or industries.

ETFs That Topped & Flopped in Q1

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)